Results 261 to 270 of about 138,687 (371)

A Genomic Sequencing Approach to Newborn Mass Screening and Its Opportunities.

JAMA Netw Open
Carli D, Quarello P, Porta F, Cagnazzo C, Zucchetti G, Proto CF, Gianasso R, Biamino E, Carbonara C, Coscia A, Parlato C, Fenoglio B, Guarrera S, Spada M, Mussa A, Minucci S, Fagioli F.   +16 more
europepmc   +1 more source

Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. [PDF]

Arthritis Rheumatol
Macaraeg M, Baker E, Handorf E, Matt M, Baker EK, Brunner H, Grom AA, Henrickson M, Huggins J, Zhang W, Lee P, Marsh R, Schulert GS.   +12 more
europepmc   +1 more source

Interleukin (IL)‐5, Eosinophils and IL‐5 Pathway Inhibitors in Eosinophilic Granulomatosis with Polyangiitis.

Arthritis &Rheumatology, Accepted Article.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology

Clinical Pharmacology &Therapeutics, EarlyView.
T‐cell engaging antibodies (TCEs) and chimeric antigen receptor (CAR) T cells (CAR‐T cells) are among precision medicine therapies that have revolutionized the treatment of hematologic cancers. Their success in oncology has piqued interest in translating this promise into additional indications, such as autoimmune disorders.
Peter Ashcroft, Sarah McFann, Alex Ferguson, Arthur Van De Vyver, Suzanne Gaudet, Eshita Khera, Jan‐Frederik Schlender   +6 more
wiley   +1 more source

Autoimmune enteropathy in an infant, a rare entity possibly triggered in utero. [PDF]

Oxf Med Case Reports
Grujic S, Gershman G.
europepmc   +1 more source

Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance is a critical component of medication safety. Despite rigorous evaluation of new drugs during clinical trials, some adverse effects might only be identified once pharmaceuticals are used by a larger population for a longer duration.
Claire Spahn, Nanase Toda, Blaine Groat, Omar Aimer, Sara Rogers, Akinyemi Oni‐Orisan, Andrew Monte, Nancy Hakooz, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +8 more
wiley   +1 more source

Atypical lymphoproliferations associated with germline genetic variants: a report of the 2024 EA4HP/SH lymphoma workshop. [PDF]

Virchows Arch
van den Brand M, Rásó-Barnett L, Gasljevic G, Balague O, Laurent C, Ponzoni M, Anagnostopoulos I, Cook JR, Dirnhofer S, Quintanilla-Martinez L, Sander B, Pittaluga S.   +11 more
europepmc   +1 more source

Break through the mold: Hyper-IgE syndrome as a vehicle for invasive aspergillosis. [PDF]

Respir Med Case Rep
Nordin J, Smetana S, Johnson R, Bartosiak A, Nassif N.   +4 more
europepmc   +1 more source

Cell migration, chimerism, and graft acceptance: with particular reference to the liver [PDF]

, 1996
Demetris, AJ, Murase, N, Ricordi, C, Starzl, TE, Trucco, M   +4 more
core  

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source